PLYX
Polaryx Therapeutics, Inc. Common Stock
NASDAQ: PLYX · HEALTHCARE · BIOTECHNOLOGY
$5.22
-7.28% today
Updated 2026-04-29
Market cap
$247.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$2 – $49
Volume
1.1M
Polaryx Therapeutics, Inc. Common Stock (PLYX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |